Top Markets
Coin of the day
PacificHealth Laboratories, Inc. PacificHealth Laboratories, Inc.

PacificHealth Laboratories, Inc.

PHLI
Classifica tra le azioni #39558
PacificHealth Laboratories, Inc. (PHLI) specializes in developing and marketing... PacificHealth Laboratories, Inc. (PHLI) specializes in developing and marketing nutritional products designed to boost overall health and enhance athletic performance for consumers both within the United States and internationally. The company's offerings predominantly target key aspects of athletic performance, such as optimal sports performance, proper hydration, sustained energy (fueling), and efficient muscle recovery. PHLI's product line includes notable items like ENDUROX R4, a drink formulated for muscle recovery; ACCELERADE, a protein-powered sports beverage; energy gels such as ACCEL GEL and 2ND SURGE; the exercise supplement ENDUROX EXCEL; and Body Glove Surge. Additionally, they provide ACCELERADE HYDRO, a specific formulation for less intense workouts, which supports hydration, energy, and recovery before, during, and after physical activity. Reaching consumers through diverse distribution channels, PHLI's products are available in sports specialty and natural product retailers and chains, as well as directly through their official website. PacificHealth Laboratories, Inc. was founded in 1995 and is headquartered in Matawan, New Jersey.
Prezzo delle azioni
$0.0001
Ultima sincronizzazione: 2025-02-11
Capitalizzazione di mercato
$438.31K
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
US
Scambia PacificHealth Laboratories, Inc. (PHLI)
EPS per PacificHealth Laboratories, Inc. (PHLI)
EPS al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di PacificHealth Laboratories, Inc., l’EPS attuale della società (TTM) è 0. Alla fine del 2026, la società aveva un EPS di 0 uguale a rispetto a quello del 2026, che era di 0.
Storico EPS per PacificHealth Laboratories, Inc. da 2026 a 2026
EPS alla fine di ogni anno
Anno EPS Cambia
Non abbastanza dati per le date fornite.
EPS per aziende simili o concorrenti